{"name":"SillaJen, Inc.","slug":"sillajen-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOS1d5X2ZDZnQ4dUxnSGdKN0lWTjdHX2JzWWdKMk1vSmczWER5XzVHM0VJX2dpVFBEUk1aYldlQkVwSlZCMHl5UUlUQU15U1ZObUtvLW5JNWVLN1VBZEZtNVB6NWZNQU9yVk5obnpPN3dsQlJMcmItaHFoM29pSVhaeFpSbEFyZjdwSUt2OTNlcHY1eXBxaHFxTFZqMjhfMkktUVhweFZpWktGWW9tclBmT0ZacFhKODlVcVMtd3VZQ09LSVFjM2FfcTlreWlHYjdac1p5czJQRC0zbzZ6Ty1aRW9MWEpHSzhBNlBvZks0d3BQbmV4WFE?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart.com","summary":"Metastatic Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 40+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Metastatic Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 40+ Pharma Companies in the Race | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOWnU3YnJCYzNuV0Y1RUFWQXpUYlFDTXhGa1hlMnhGRjAyRy01WXNJc05KSmd3RUVKZmV0aUxXWjVPbkV2dkhwb0s1NFdOWTRKSUVvYW8zdFNGSGJQSG5NMzFVQnB3WC12dS1ZQ3VPQnJ0a3pkVzdfTUlaMmV1bEp4VVJ1YS1QTmRBYlpJOGNYQ0c0M3VFcmZyeVhLTnJQcENYcmdkTHNWSmZiam45YlBwRVI0eHhJNkJPX0ZjdE1mZ2hOX0c5dVRNeUZtOU1LUzNpQjJhZ2NwNmpTQlBoSlh0VmpxbDBaWkZQX05YVmlvMFRzZXc2bnBRd2RrS3hNZFphTVhkT2hCc3BMUlliNHd3bXl3ZnJXa3M5NEFqR1ZNdHlERG_SAaMCQVVfeXFMTlp1N2JyQmMzbldGNUVBVkF6VGJRQ014RmtYZTJ4RkYwMkctNVlzSXNOSkpnd0VFSmZldGlMV1o1T25FdnZIcG9LNTRXTlk0SklFb2FvM3RTRkhiUEhuTTMxVUJwd1gtdnUtWUN1T0JydGt6ZFc3X01JWjJldWxKeFVSdWEtUE5kQWJaSThjWENHNDN1RXJmcnlYS05yUHBDWHJnZExzVkpmYmpuOWJQcEVSNHh4STZCT19GY3RNZmdoTl9HOXVUTXlGbTlNS1MzaUIyYWdjcDZqU0JQaEpYdFZqcWwwWlpGUF9OWFZpbzBUc2V3Nm5wUXdka0t4TWRaYU1YZE9oQnNwTFJZYjR3d215d2ZyV2tzOTRBakdWTXR5RERv?oc=5","date":"2026-02-04","type":"trial","source":"Bolsamania","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Bolsamania","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNYU5keXB5YnJROWcxUlNMLXN2b1JIcTRyZzgwM0xyRThaNEFWN3M0UHIzOTQwZGVnWTNWLXFHSHR2NHRLOU51aWJxX1VDelBvb3IySzRMR0hMcFZmV01IUUREZ2tvS0I5SUxyQ0dPcU9jNWNGWURyX2xRUy1Pd0tiaC12bEtSRDBWQkZ2bFQ0cUo2ck9ISklZUGRMNzREb3BhYVlPWWVod21hRDF0QkVmcHNKY0M0Mkx0QWlBOQ?oc=5","date":"2025-10-27","type":"regulatory","source":"Fierce Biotech","summary":"First FDA IND Milestone Achieved Using Human Vascularized Organoid Efficacy Data - Fierce Biotech","headline":"First FDA IND Milestone Achieved Using Human Vascularized Organoid Efficacy Data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFB2d2xHcUZnY29zb0lCbVBCWUdwLUk1X0NfODBpVGJBS0ZlNWhOVnFPNFRNaVBhTkJVWE1BTU9GcjNUY1djQkRqU2oyQ1FmeU1LdHNJb0kxWnZaR1RNc0kwbGw0eFVXUnNsd2pELXlB?oc=5","date":"2025-03-18","type":"pipeline","source":"KED Global","summary":"SillaJen: First to use lab-grown human tissue to find best cancer drug dose - KED Global","headline":"SillaJen: First to use lab-grown human tissue to find best cancer drug dose","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5SYmJYSmtrWGdNaFVuanlkQkUtOFZ3RUdJZGJTX19Bd3RtVlFGX1kzcXByZmlDN0UyMGRlcjE2QjdpS3dYWlFjT2pLeG1WWFRTYmxLeWFUZ2VfSjRnVkcxbkxUWEpPaHczUGZfX2ZB0gFyQVVfeXFMTUhDQzJ0dk91ZC1vZ1Y3Z08wMkF2LXd1V2xRQTZPYW1EM2ZzYWpvT0JkSHhXQi10TkpkbGtiWklVRlNfZ2QweHB2aWJkUmRUNV9rbWNxc0VCMUJQaThpUEpKOG9lc2VGQ3EtRzI3d2I0bktn?oc=5","date":"2025-03-14","type":"deal","source":"koreabiomed.com","summary":"Sillajen acquires orthopedic implant developer to boost pharma biz - koreabiomed.com","headline":"Sillajen acquires orthopedic implant developer to boost pharma biz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9sd0NfMm02T2hKYlBySGVBQUhfSzhrSk1MazZlbm81Q3ZBNVRveTQza2hKdGJrbVNtTGZ5VWJ6eHY3bkhoUGFzcW5fTE5JWDJRcFYtOWJVU1Y3RUJ6bmJIb3B1TnJpbFE4ckdSZTFB?oc=5","date":"2023-02-27","type":"trial","source":"KED Global","summary":"SillaJen starts US trial of anti-cancer drug from Basilea - KED Global","headline":"SillaJen starts US trial of anti-cancer drug from Basilea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5saTE3dTNZNmJwTU5ndGpDSkNDeXZPelhNSHRTMnhnRS1oMnhLWl9fSlNkT093UkozUllYM2VvMEVDcTVFSjdtNU9nY2tFWl9mVVY0SVY2cVVZNTlnWjJKeHV4aUp3Rk83dTViQ3BpTG92c1JXUGx0X3JkQUdxMkU?oc=5","date":"2022-12-28","type":"pipeline","source":"KED Global","summary":"M2N to sell 52% stake in Chinese automotive parts company DKCA - KED Global","headline":"M2N to sell 52% stake in Chinese automotive parts company DKCA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAyMl8zNkRsekdhcW9tM3g0Wk9XSjRxVlIyVThaMHlrTHVvQVpfZEJsSGNNRXB1UXFJTEVOS3oyXzZDeHFocUtDc3FNd09abzdQWTh0V3J5RVhiQjVpUEJVMHB2QnB2UXlmSC1RbHRn?oc=5","date":"2022-12-23","type":"pipeline","source":"KED Global","summary":"Dong-A ST incorporates NeuroBo as subsidiary - KED Global","headline":"Dong-A ST incorporates NeuroBo as subsidiary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5IZWxCd1ZROXF0OGprRk9leDh6dTlxVmRTU1NSeU5tTWtvcUwyM2F6Ny1GTWhsVjFibmpfZ0c4TjgyaV9lOFVGUTkyMmRza3BDVFpWNXhoUWpET2VVU28yaFNlYkk3R0hIdS1VeENn?oc=5","date":"2022-10-13","type":"pipeline","source":"KED Global","summary":"SillaJen shares jump as exchange maintains listing, allows resumed trade - KED Global","headline":"SillaJen shares jump as exchange maintains listing, allows resumed trade","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}